Skip to content

Educational Video to Improve Nursing Home Care in End-stage Dementia

Educational Video to Improve Nursing Home Care in End-stage Dementia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01774799
Acronym
EVINCE
Enrollment
804
Registered
2013-01-24
Start date
2013-03-31
Completion date
2017-08-31
Last updated
2019-10-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced Dementia

Keywords

advanced dementia, advance care planning, nursing home

Brief summary

This is a 5-year cluster RCT of a video Advance Care Planning intervention vs. control among 360 nursing home residents with advanced dementia (N=180/arm) in 20 matched nursing homes (10 intervention/10 control). Clinical outcomes will be collected at baseline, and quarterly (up to 12-months) regarding goals of care preferences, advance care planning, and treatments received. The primary outcome is decisions not to be hospitalized at 6 months.

Detailed description

The over-riding goal of the EVINCE study is to conduct a cluster RCT of a video Advance Care Planning intervention in nursing home residents with advanced dementia. A total of 360 nursing home residents with advanced dementia (N=180/arm) in 20 matched nursing homes (10 intervention/10 control) will be recruited. These residents' proxies with also be recruited for a total sample size of 720 residents and proxies (resident/proxy dyads). Outcomes will be compared between residents in the intervention vs, control nursing homes at baseline and every 3 months up to 12 months. At baseline proxies of residents in the intervention nursing homes will view a 12-minutes video describing three level of care options in advanced dementia (intensive, basic and comfort) and their choice will be communicated to the resident's primary care providers. Residents in the control nursing homes will receive the usual advance care planning practiced in those facilities. UPDATE SEPT 19, 2014: During the first 18 months of the study, recruitment of resident/proxy dyads was lower per facility than anticipated at the time of study design. Therefore, the number of matched pairs of NH recruited was increased. As of September 19, 2014, 19 NH pairs (38 NHs) were recruited and randomized with a plans to continue to up to 30 pairs as needed. NHs were originally randomized using a paired approach matched for for-profit status and whether or not the NH had a special care dementia unit (SCU). In March 2014, the state of Massachusetts changed legislation defining an SCU. Many of the changes focused on specifics of staff training. As a result, SCUs in several participating facilities did not meet the new criteria and lost this official designation, although the actual clinical structure of the existing units did not change. Nonetheless, we opted to maintain the initial matching criteria of the first 19 NHs which included SCU based on the definition before the Massachusetts legislation change, but dropped this matching criterion after the legislation change. Thus, beginning with matched pair 20, NHs were matched solely on for-profit status. UPDATE MARCH 2016 To reach subject recruitment numbers, additional facilities were recruited. As of this date, 60 NHs (30/arm) have been recruited, randomized and have had subject enrolled. To achieve additional for power for Outcome 2, (aquisition of new decisions to forego hospitalizations) the target sample size was increased to 400.

Interventions

OTHERControl group

Sponsors

National Institute on Aging (NIA)
CollaboratorNIH
National Institutes of Health (NIH)
CollaboratorNIH
Hebrew SeniorLife
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age \> 65 * A diagnosis of dementia (any type) * Global Deterioration Scale (GDS) score of 7 * Nursing home length of stay \> 30 days * Proxy is available who can speak in English * Proxy must either live within a 60 mile radius of Boston or be available to come to the residents nursing home within 2 weeks of recruitment in order to conduct the in-person baseline interview.

Exclusion criteria

* Residents with cognitive impairment due to causes other than dementia (e.g. head trauma) and in short-term, sub-acute SNFs will be excluded

Design outcomes

Primary

MeasureTime frameDescription
Documented Decisions to Forgo Hospitalizationby six monthsThe proportion of residents with this outcome will be considered cumulatively at 6 months, including those who died; i.e., a composite of the percent of residents alive at six months who had a decision not to hospitalize and those who died before six months with this outcome prior to death. This cumulative outcome will only be based on time points following baseline as the baseline chart review data is conducted before the baseline proxy interview (i.e., before the proxy has seen the video in the intervention arm or heard options verbally in the control arm). (Decisions to forehospitalizations will be examined in a similar fashion at 3, 9, and 12 months, however the six month time frame is the primary trial outcome)

Secondary

MeasureTime frameDescription
Acquisition of Preference for Level of Care6 monthsThe proportion of proxies who have chosen comfort care (versus intermediate or intensive care) based on telephone interviews will be considered cumulatively at each assessment. At 6 months the outcome will include the proportion of proxies choosing comfort care up to and including the 6 month interview. Cumulative proportions will include data from the baseline interview for the control group, and baseline immediate post video interview for intervention group.The proportion of proxies choosing comfort care will be compared between the intervention and control groups using an extension of logistic regression based on general estimating equations (GEE) to account for clustering at the NH level at each time period.
Acquisition of Decisions Not to Hospitalizeby 12 monthsThis is a sub primary outcome. The modified ITT population will be the subgroup of residents who begin the study without a documented decision to forego hospitalization, and the outcome will be acquisition of a documented decision to forego hospitalization over the 12 month follow-up period. The analysis will utilize Cox proportional hazards regression. Results will be summarized using a hazard ratio and associated 95% confidence interval as well as plots of the cumulative incidence by group.

Other

MeasureTime frameDescription
Acquisition of Other Documented Advance Care Planningby 6 monthsThe proportion of residents who acquired a documented advance directive to forego tube-feeding will be compared in the intervention versus control group.
Burdensome Treatmentsby 12 monthsBurdensome treatments include: Hospitals transfers (hospitalizations or emergency room visits), tube feeding or parenteral therapy. The rate of burdensome treatments per 1000 resident days was compared between the intervention and control arms.

Countries

United States

Participant flow

Pre-assignment details

Participants are analyzed as dyads; proxies and patients.There are 402 dyads, for a total of 804 participants.

Participants by arm

ArmCount
Advance Care Planning Intervention Residents
Residents with advanced dementia in intervention group
212
Usual Care (Control Group) Residents
Residents with advanced dementia in control group
190
Advance Care Planning Intervention Proxies
Proxies of residents with advanced dementia in intervention group
212
Usual Care (Control Group) Proxies
Proxies of residents with advanced dementia in control group
190
Total804

Withdrawals & dropouts

PeriodReasonFG000FG001FG002FG003
Overall StudyLost to Follow-up1100

Baseline characteristics

CharacteristicAdvance Care Planning Intervention ResidentsUsual Care (Control Group) ResidentsAdvance Care Planning Intervention ProxiesUsual Care (Control Group) ProxiesTotal
Age, Continuous86.0 years
STANDARD_DEVIATION 7.4
87.4 years
STANDARD_DEVIATION 7.3
61.8 years
STANDARD_DEVIATION 10.9
62.8 years
STANDARD_DEVIATION 10.6
74.5 years
STANDARD_DEVIATION 9.1
Race/Ethnicity, Customized
non-white
34 Participants18 Participants35 Participants17 Participants104 Participants
Race/Ethnicity, Customized
white
178 Participants172 Participants177 Participants173 Participants700 Participants
Region of Enrollment
United States
212 participants190 participants212 participants190 participants804 participants
Sex: Female, Male
Female
167 Participants156 Participants146 Participants120 Participants589 Participants
Sex: Female, Male
Male
45 Participants34 Participants66 Participants70 Participants215 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
86 / 21289 / 190
other
Total, other adverse events
0 / 2120 / 190
serious
Total, serious adverse events
0 / 2120 / 0

Outcome results

Primary

Documented Decisions to Forgo Hospitalization

The proportion of residents with this outcome will be considered cumulatively at 6 months, including those who died; i.e., a composite of the percent of residents alive at six months who had a decision not to hospitalize and those who died before six months with this outcome prior to death. This cumulative outcome will only be based on time points following baseline as the baseline chart review data is conducted before the baseline proxy interview (i.e., before the proxy has seen the video in the intervention arm or heard options verbally in the control arm). (Decisions to forehospitalizations will be examined in a similar fashion at 3, 9, and 12 months, however the six month time frame is the primary trial outcome)

Time frame: by six months

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Advance Care Planning InterventionDocumented Decisions to Forgo Hospitalization133 Participants
Usual CareDocumented Decisions to Forgo Hospitalization119 Participants
95% CI: [0.69, 1.69]
Secondary

Acquisition of Decisions Not to Hospitalize

This is a sub primary outcome. The modified ITT population will be the subgroup of residents who begin the study without a documented decision to forego hospitalization, and the outcome will be acquisition of a documented decision to forego hospitalization over the 12 month follow-up period. The analysis will utilize Cox proportional hazards regression. Results will be summarized using a hazard ratio and associated 95% confidence interval as well as plots of the cumulative incidence by group.

Time frame: by 12 months

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Advance Care Planning InterventionAcquisition of Decisions Not to Hospitalize41 Participants
Usual CareAcquisition of Decisions Not to Hospitalize30 Participants
95% CI: [0.66, 2.2]
Secondary

Acquisition of Preference for Level of Care

The proportion of proxies who have chosen comfort care (versus intermediate or intensive care) based on telephone interviews will be considered cumulatively at each assessment. At 6 months the outcome will include the proportion of proxies choosing comfort care up to and including the 6 month interview. Cumulative proportions will include data from the baseline interview for the control group, and baseline immediate post video interview for intervention group.The proportion of proxies choosing comfort care will be compared between the intervention and control groups using an extension of logistic regression based on general estimating equations (GEE) to account for clustering at the NH level at each time period.

Time frame: 6 months

Population: Missing data are due to missing proxy interviews at certain follow-up time points

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Advance Care Planning InterventionAcquisition of Preference for Level of Care151 Participants
Usual CareAcquisition of Preference for Level of Care133 Participants
95% CI: [0.58, 1.58]
Other Pre-specified

Acquisition of Other Documented Advance Care Planning

The proportion of residents who acquired a documented advance directive to forego tube-feeding will be compared in the intervention versus control group.

Time frame: by 6 months

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Advance Care Planning InterventionAcquisition of Other Documented Advance Care Planning148 Participants
Usual CareAcquisition of Other Documented Advance Care Planning117 Participants
95% CI: [1.13, 2.82]
Other Pre-specified

Burdensome Treatments

Burdensome treatments include: Hospitals transfers (hospitalizations or emergency room visits), tube feeding or parenteral therapy. The rate of burdensome treatments per 1000 resident days was compared between the intervention and control arms.

Time frame: by 12 months

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Advance Care Planning InterventionBurdensome Treatments33 Participants
Usual CareBurdensome Treatments25 Participants
p-value: 0.32Regression, Linear

Source: ClinicalTrials.gov · Data processed: Feb 24, 2026